Porex has a history of developing, manufacturing and distributing bioimplantable porous polyethylene products for reconstructive surgery of the head and face. The product portfolio will complement Stryker’s current hold in the craniomaxillofacial market.
The terms of the transaction were not disclosed. However, it is expected to be neutral to Stryker’s 2010 and 2011 earnings per share and then accretive thereafter.
Read the Stryker news release on the transaction.
Read other coverage on Stryker:
– Stryker Acquires Boston Scientific Corp.’s Neurovascular Business for $1.5B
– Stryker Reports a 7% Net Sales Increase for 3Q 2010
– Stryker Acquires Gaymar Industries for $150M
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
